Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer.
Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer.
Clin Adv Hematol Oncol. 2016 Mar;14(3):165-167
Authors: Brahmer JR
PMID: 27058029 [PubMed - as supplied by publisher]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research